National Pension Service’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.7M Buy
198,295
+14,506
+8% +$4.38M 0.04% 328
2026
Q1
$60.8M Buy
183,789
+15,640
+9% +$5.32M 0.05% 295
2025
Q4
$66.9M Sell
168,149
-9,089
-5% -$4.02M 0.05% 265
2025
Q3
$80.8M Buy
177,238
+2,192
+1% +$893K 0.06% 230
2025
Q2
$57.1M Buy
175,046
+1,387
+0.8% +$384K 0.05% 273
2025
Q1
$46.9M Buy
173,659
+14,148
+9% +$3.64M 0.05% 300
2024
Q4
$37.5M Sell
159,511
-36,876
-19% -$9.7M 0.04% 356
2024
Q3
$54M Hold
196,387
0.05% 294
2024
Q2
$47.7M Buy
196,387
+10,204
+5% +$1.61M 0.05% 283
2024
Q1
$27.8M Buy
186,183
+18,413
+11% +$3.07M 0.03% 447
2023
Q4
$32.1M Hold
167,770
0.04% 343
2023
Q3
$29.4M Sell
167,770
-4,215
-2% -$804K 0.05% 338
2023
Q2
$32.9M Buy
171,985
+15,755
+10% +$3.12M 0.05% 323
2023
Q1
$30.5M Hold
156,230
0.06% 323
2022
Q4
$37.1M Sell
156,230
-757
-0.5% -$161K 0.07% 281
2022
Q3
$32.9M Sell
156,987
-23,911
-13% -$4.56M 0.07% 288
2022
Q2
$26.4M Hold
180,898
0.05% 362
2022
Q1
$29.5M Buy
180,898
+5,105
+3% +$778K 0.05% 395
2021
Q4
$29.8M Sell
175,793
-5,310
-3% -$987K 0.05% 412
2021
Q3
$34.2M Sell
181,103
-1,758
-1% -$330K 0.07% 335
2021
Q2
$31M Hold
182,861
0.06% 384
2021
Q1
$25.8M Sell
182,861
-7,052
-4% -$1.06M 0.05% 424
2020
Q4
$24.7M Buy
189,913
+16,787
+10% +$2.24M 0.06% 410
2020
Q3
$24.2M Hold
173,126
0.06% 335
2020
Q2
$25.6M Buy
+173,126
New +$23.3M 0.07% 302
2018
Q2
Sell
-100,913
Closed -$12M 462
2018
Q1
$12M Buy
+100,913
New +$13M 0.06% 406

Other funds holding ALNY

National Pension Service's ALNY Position: Q2 2026 in Review

National Pension Service increased its Alnylam Pharmaceuticals (ALNY) stake by 7.9% in Q2 2026, buying an estimated $4.38M and bringing the position to 198,295 shares worth $59.7M. The position accounts for 0.04% of the portfolio, ranked #328.

National Pension Service first reported a position in ALNY in Q1 2018 and has held it in 26 quarters since. The position peaked at $80.8M in Q3 2025. 594 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • National Pension Service held 198,295 shares of Alnylam Pharmaceuticals worth $59.7M as of Q2 2026.
  • National Pension Service bought 14,506 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $4.38M.
  • Alnylam Pharmaceuticals made up 0.04% of National Pension Service's portfolio in Q2 2026, its #328 holding.
  • National Pension Service first reported a position in Alnylam Pharmaceuticals in Q1 2018 and has held it in 26 quarters since.
  • National Pension Service's Alnylam Pharmaceuticals position peaked at $80.8M in Q3 2025.
  • 594 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on National Pension Service's 13F filing for Q2 2026, filed 13 Aug 2026.